Terms: = Brain cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Prognosis
18 results:
1. Loss of SATB2 and CDX2 expression is associated with DNA mismatch repair protein deficiency and BRAF mutation in colorectal cancer.
Li J; Zeng Q; Lin J; Huang H; Chen L
Med Mol Morphol; 2024 Mar; 57(1):1-10. PubMed ID: 37583001
[TBL] [Abstract] [Full Text] [Related]
2. SMARCB1/INI1-Deficient Poorly Differentiated Carcinoma of the Colon With Rhabdoid Features-A Rare Tumor With Serrated Phenotype: Case Report and Review of Literature.
Maurya S; Yadav S; Bhowmik S; Dhal J; Mehra L; Sharma R; Krishna A; Sharma A; Barwad A; Das P
Int J Surg Pathol; 2024 Feb; 32(1):187-195. PubMed ID: 37128676
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma.
Zhang Q; Sun Y; Wang C; Shao F
Bioengineered; 2022 Mar; 13(3):6258-6271. PubMed ID: 35212617
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of nras.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract] [Full Text] [Related]
5. [A prognostic nomogram for metastasized colorectal cancer patients treated with cetuximab].
Zhong LP; Li D; Zhu LZ; Fang XF; Xiao Q; Ding KF; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):701-708. PubMed ID: 32683833
[No Abstract] [Full Text] [Related]
6. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
Mitre V; Heym K; Clark GD; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
[TBL] [Abstract] [Full Text] [Related]
7. The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13.
Hu Y; Zhang M; Tian N; Li D; Wu F; Hu P; Wang Z; Wang L; Hao W; Kang J; Yin B; Zheng Z; Jiang T; Yuan J; Qiang B; Han W; Peng X
J Clin Invest; 2019 May; 129(8):3072-3085. PubMed ID: 31112526
[TBL] [Abstract] [Full Text] [Related]
8. Survival and prognostic factors in surgically treated brain metastases.
Kavouridis VK; Harary M; Hulsbergen AFC; Lo YT; Reardon DA; Aizer AA; Iorgulescu JB; Smith TR
J Neurooncol; 2019 Jun; 143(2):359-367. PubMed ID: 30989623
[TBL] [Abstract] [Full Text] [Related]
9. EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).
Cardona AF; Rojas L; Zatarain-Barrón ZL; Freitas HC; Granados ST; Castillo O; Oblitas G; Corrales L; Castro CD; Ruiz-Patiño A; Martín C; Pérez MA; González L; Chirinos L; Vargas C; Carranza H; Otero J; Rodriguez J; Rodriguez J; Archila P; Lema M; Acosta Madiedo J; Karachaliu N; Wills B; Pino LE; de Lima V; Rosell R; Arrieta O;
Lung Cancer; 2018 Nov; 125():265-272. PubMed ID: 30429031
[TBL] [Abstract] [Full Text] [Related]
10. RNA-binding Protein UNR Promotes Glioma Cell Migration and Regulates the Expression of Ribosomal Protein L9.
Tian NY; Qi YJ; Hu Y; Yin B; Yuan JG; Qiang BQ; Peng XZ; Han W
Chin Med Sci J; 2018 Sep; 33(3):143-151. PubMed ID: 30266104
[TBL] [Abstract] [Full Text] [Related]
11. Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
Lee SH; Kim JE; Jang HS; Park KH; Oh BH; Shin SJ; Chung KY; Roh MR; Rha SY
Cancer Res Treat; 2018 Oct; 50(4):1378-1387. PubMed ID: 29361821
[TBL] [Abstract] [Full Text] [Related]
12. Association between clinicopathological characteristics and RAS mutation in colorectal cancer.
Rimbert J; Tachon G; Junca A; Villalva C; Karayan-Tapon L; Tougeron D
Mod Pathol; 2018 Mar; 31(3):517-526. PubMed ID: 29052598
[TBL] [Abstract] [Full Text] [Related]
13. Identification and functional analysis of the risk microRNAs associated with cerebral low-grade glioma prognosis.
Liu X; Song B; Li S; Wang N; Yang H
Mol Med Rep; 2017 Aug; 16(2):1173-1179. PubMed ID: 28586047
[TBL] [Abstract] [Full Text] [Related]
14. miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of nras.
Fiore D; Donnarumma E; Roscigno G; Iaboni M; Russo V; Affinito A; Adamo A; De Martino F; Quintavalle C; Romano G; Greco A; Soini Y; Brunetti A; Croce CM; Condorelli G
Oncotarget; 2016 Apr; 7(15):19531-47. PubMed ID: 26799668
[TBL] [Abstract] [Full Text] [Related]
15. RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer.
Yaeger R; Cowell E; Chou JF; Gewirtz AN; Borsu L; Vakiani E; Solit DB; Rosen N; Capanu M; Ladanyi M; Kemeny N
Cancer; 2015 Apr; 121(8):1195-203. PubMed ID: 25491172
[TBL] [Abstract] [Full Text] [Related]
16. The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.
Magnus N; Meehan B; Garnier D; Hashemi M; Montermini L; Lee TH; Milsom C; Pawlinski R; Ohlfest J; Anderson M; Mackman N; Rak J
Biochem Biophys Res Commun; 2014 Nov; 454(2):262-8. PubMed ID: 25450387
[TBL] [Abstract] [Full Text] [Related]
17. MEK targeting in n-ras mutated metastatic melanoma.
Thumar J; Shahbazian D; Aziz SA; Jilaveanu LB; Kluger HM
Mol Cancer; 2014 Mar; 13():45. PubMed ID: 24588908
[TBL] [Abstract] [Full Text] [Related]
18. Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.
Kieran MW; Roberts CW; Chi SN; Ligon KL; Rich BE; Macconaill LE; Garraway LA; Biegel JA
Pediatr Blood Cancer; 2012 Dec; 59(7):1155-7. PubMed ID: 22997201
[TBL] [Abstract] [Full Text] [Related]